VA
Personalis Reports Preliminary Q4 Revenues up More Than 2 Percent
The company is expecting continued growth in its oncology orders in Q4 2021 to translate to significant revenue growth for that business next year.
Castle Biosciences Awarded VA Supply Contract for Melanoma Test
The company said the contract will provide greater access to its DecisionDx-Melanoma gene expression profile test for veterans and active duty military.
Personalis Q2 Revenues Rise 11 Percent
Revenues from the Veterans Affairs Million Veteran Program shrank slightly while those from non-VA MVP customers were up 74 percent.
Personalis Q1 Revenues Grow 9 Percent
The firm tallied $20.9 million in revenues compared to $19.2 million a year ago, edging analysts' consensus estimate of $20.4 million.
Renalytix AI Lands US Government Contract for Kidney Disease Test
The firm said that the contract covers early-stage kidney disease testing that can be provided by more than 140 US government departments, agencies, and affiliates.
Nov 5, 2020
Personalis Q3 Revenues Up 16 Percent
Aug 6, 2020
Personalis Q2 Revenues Up 23 Percent
May 7, 2020
Personalis Q1 Revenues Up 36 Percent
Nov 13, 2019
Personalis Q3 Revenues Up 47 Percent
Jul 11, 2019
Mar 12, 2019